Showing results (1101-1110 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|May 16, 2008
Models for the analysis of C-reactive protein in statin trialsHarry Southworth, Aaron DanePharmaceutical Statistics|April 3, 2014
Utility values in health technology assessments: a statistician's perspectiveCaroline Whately-Smith, Claire Watkins, Helen Mann, et al.Pharmaceutical Statistics|March 27, 2014
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approachSara Hughes, Karen Wells, Paul McSorley, et al.Pharmaceutical Statistics|May 3, 2014
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome dataCornelia Ursula Kunz, Tim Friede, Nick Parsons, et al.Pharmaceutical Statistics|February 6, 2014
Sample size determination for the weighted log-rank test with the Fleming-Harrington class of weights in cancer vaccine studiesTakahiro HasegawaPharmaceutical Statistics|April 10, 2014
Blinded sample size re-estimation in crossover bioequivalence trialsDaniel Golkowski, Tim Friede, Meinhard KieserPharmaceutical Statistics|September 29, 2016
A comparison of five approaches to decision-making for a first clinical trial of efficacySimon Kirby, Christy Chuang-SteinPharmaceutical Statistics|January 24, 2017
A simulation study of methods for selecting subgroup-specific doses in phase 1 trialsSatoshi Morita, Peter F Thall, Kentaro TakedaPharmaceutical Statistics|March 18, 2021
Using recurrent time-to-event models with multinomial outcomes to generate toxicity profilesVal Gebski, Ian Marschner, Rebecca Asher, et al.Pharmaceutical Statistics|March 19, 2021
Power and sample size for GEE analysis of incomplete paired outcomes in 2 × 2 crossover trialsYongqiang TangPageof 120